Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Timing and Accuracy of HSV IgG Serology

Antibody Development Timeline

  • Detectable HSV‑specific IgG antibodies typically do not appear until up to 12 weeks after exposure, making serologic testing performed earlier prone to false‑negative results. 1
  • The incubation period for HSV‑1 and HSV‑2 ranges from 2 to 10 days (up to 4 weeks) for symptom onset, which is distinct from the later timeline of antibody development. 2
  • Testing for HSV IgG before 12 weeks post‑exposure should be deferred; repeat serology is recommended no sooner than 12 weeks after the suspected exposure. 1

Baseline Test Performance (≥12 Weeks)

  • At the optimal ≥12‑week timepoint, commercial HSV‑1 IgG assays have an approximate sensitivity of 70 % (≈30 % false‑negatives). 1
  • At the optimal ≥12‑week timepoint, commercial HSV‑2 IgG assays have an approximate sensitivity of 92 % (≈8 % false‑negatives). 1

Accuracy of Early (3–4 Week) Testing

  • At 3–4 weeks post‑exposure, the accuracy of HSV IgG testing is essentially unknown but is presumed to be substantially lower than the baseline sensitivities because many patients have not yet seroconverted. 1
  • A negative HSV IgG result obtained at 3–4 weeks is clinically meaningless and cannot exclude infection. 1
  • A positive HSV IgG result obtained at 3–4 weeks may reflect cross‑reactivity or prior infection rather than recent exposure. 1

Clinical Recommendations – Active Lesions

  • Perform HSV nucleic acid amplification testing (NAAT/PCR) directly from the lesion; this is the gold‑standard diagnostic method with >90 % sensitivity and specificity. 1
  • Do not rely on serology when lesions are available for direct testing. 1

Clinical Recommendations – No Lesions

  • Wait until ≥12 weeks after suspected exposure before ordering type‑specific HSV‑1 and HSV‑2 IgG serology. 1
  • Use assays that detect antibodies to HSV glycoprotein G‑1 and G‑2 via enzyme immunoassay (EIA) or chemiluminescent immunoassay (CLIA). 1

Critical Pitfalls to Avoid

  • Do not tell patients that a negative HSV serology at any timepoint definitively excludes infection; false‑negative rates remain substantial (≈30 % for HSV‑1, ≈8 % for HSV‑2 even at optimal timing). 1
  • When HSV‑2 serology yields a low index value (1.1–2.9), specificity drops to approximately 39.8 %, indicating that confirmatory testing should be considered. 1
  • Individuals with prior HSV‑1 infection are more prone to false‑positive HSV‑2 results when the HSV‑2 index value is low. 1

Bottom Line

  • There is no reliable accuracy percentage for HSV IgG testing at 3–4 weeks because antibodies have not yet developed in most patients; the appropriate actions are either lesion PCR testing or waiting until 12 weeks post‑exposure for serology. 1